Four researchers have been jointly awarded the prestigious Lundbeck Foundation Brain Prize in recognition of their contributions to our understanding of Alzheimer’s disease.
Browsing: Alzheimer’s disease
A recent study suggests that beta-amyloid may be transmissable during surgery, but how strong is the evidence?
As more Alzheimer’s research programs are terminated, check out our highlights from the latest neuroscience and neurology industry headlines.
Researchers have observed improvements in the cognitive function of mice after reversing the formation of beta-amyloid plaques.
Ruth Wood, co-creator of the Honeycomb maze, describes how the new test overcomes the challenges of its predecessors, and how it can be utilized across the spectrum of neuroscience research.
Pleiotropy and promiscuity in pharmacogenomics for the treatment of Alzheimer’s disease and related risk factors
Discover the genes being targeted by novel Alzheimer’s treatments and how polytherapy may be optimized in treatment of the disease, in this review from Future Neurology.
A collaborative study from researchers in Poland and Sweden has presented a novel combination of mechanisms that may lead to neuronal cell death in Alzheimer’s disease.
Genetics are a risk factor for developing dementia due to Alzheimer’s disease and now several Alzheimer’s prevention trials are focused on individuals, who based on their age and genetic profile, are at high risk for developing the disease.
In this review from Neurodegenerative Disease Management, explore current research into visual dysfunction in Alzheimer’s disease pathology.
A new study from TauRx reports success in reversing symptoms of Parkinson’s disease in mouse models treated with LTMX.